Medical-device intelligence
Boston Scientific: selected FDA company records
Explore selected Boston Scientific source names, with a cited corporate filing and separate FDA histories.
Included source names
Membership is based on Boston Scientific, 2025 Form 10-K, Exhibit 21 ↗, as of Jan 31, 2026. Mapping checked Nov 19, 2026. This is a selected research group, not a complete corporate family or a statement of current ownership.
- Boston Scientific Corporation
- Boston Scientific Scimed, Inc.
- Boston Scientific Neuromodulation Corporation
- Apollo Endosurgery, Inc.
- Baylis Medical Company Inc.
- Axonics, Inc.
Matching FDA profiles
- Boston Scientific Corporation · 1,346 records
- Boston Scientific Scimed, Inc. · 35 records
- Boston Scientific Neuromodulation Corporation · 27 records
- Apollo Endosurgery Inc · 13 records
- Baylis Medical Company Inc. · 27 records
- Axonics, Inc. · 6 records
Record activity in this scope
314 clearance records and 1,140 recall records in the covered releases, across 6 source company names and 152 product codes. Dated history runs from Jan 14, 1983 to Sep 30, 2026.
Monthly counts through October 2026
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 3 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 7 |
| January 2026 | 0 | 0 |
| February 2026 | 1 | 1 |
| March 2026 | 2 | 4 |
| April 2026 | 0 | 4 |
| May 2026 | 2 | 14 |
| June 2026 | 1 | 14 |
| July 2026 | 4 | 5 |
| August 2026 | 2 | 4 |
| September 2026 | 1 | 2 |
| October 2026 | 0 | 0 |
Product codes represented
Clearances and recall records
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| FARADRIVE STEERABLE SHEATH (CLEAR) - US, used to facilitate access to the vasculature and into the chambers of the heart, Material Number M004PF2…Z-2756-2026 · DRA | Boston Scientific Corporation | Recall | Jul 20, 2026FDA classification date |
| FARADRIVE STEERABLE SHEATH CLEAR OUS, used to facilitate access to the vasculature and into the chambers of the heart, Material Number M004PFCE21…Z-2757-2026 · DRA | Boston Scientific Corporation | Recall | Jul 20, 2026FDA classification date |
| FARASTAR Ablation Generator EU, Pulsed Field Ablation Generator, Product ID 61M401; Percutaneous Cardiac Ablation CatheterZ-2750-2026 · QZI | Boston Scientific Corporation | Recall | Jul 17, 2026FDA classification date |
| FARASTAR Pulsed Field Ablation Generator, Product ID M004PFCE61M401; Percutaneous Cardiac Ablation CatheterZ-2751-2026 · QZI | Boston Scientific Corporation | Recall | Jul 17, 2026FDA classification date |
| FARASTAR PFA Generator, Product ID M004PFCE61M460; Percutaneous Cardiac Ablation CatheterZ-2752-2026 · QZI | Boston Scientific Corporation | Recall | Jul 17, 2026FDA classification date |
| FARASTAR Ablation Generator EU, Pulsed Field Ablation Generator, Product ID 61M401; Percutaneous Cardiac Ablation CatheterZ-2753-2026 · QZI | Boston Scientific Corporation | Recall | Jul 17, 2026FDA classification date |
| WallFlex Esophageal Stent System;Agile Esophageal Over-the-Wire (OTW) Stent SystemK261978 · ESW | Boston Scientific Corporation | 510(k) | Jul 10, 2026FDA decision date |
| Rapid Refill Continuous Injection System, UPN M00566001Z-2725-2026 · KYZ | Boston Scientific Corporation | Recall | Jul 10, 2026FDA classification date |
| Intracept Access Instruments, Description/REF: INTRACEPT ACCESS INSTRUMENTS- DRILL/RLV0035, INTRACEPT ACCESS INSTRUMENTS- DRILL EU/RLV0035-EU, IN…Z-2694-2026 · GXI | Boston Scientific Neuromodulation Corporation | Recall | Jul 8, 2026FDA classification date |
| CRE Pro Wireguided 6-8mm 240cmZ-2626-2026 · FGE | Boston Scientific Corporation | Recall | Jul 1, 2026FDA classification date |
| CRE Pro Wireguided 8-10mm 240cmZ-2627-2026 · FGE | Boston Scientific Corporation | Recall | Jul 1, 2026FDA classification date |
| CRE Pro Wireguided 10-12mm 240cmZ-2628-2026 · FGE | Boston Scientific Corporation | Recall | Jul 1, 2026FDA classification date |
| CRE Pro Wireguided 12-15mm 240cmZ-2629-2026 · FGE | Boston Scientific Corporation | Recall | Jul 1, 2026FDA classification date |
| CRE Pro Wireguided 15-18mm 240cmZ-2630-2026 · FGE | Boston Scientific Corporation | Recall | Jul 1, 2026FDA classification date |
| CRE Pro Wireguided 18-20mm 240cmZ-2631-2026 · FGE | Boston Scientific Corporation | Recall | Jul 1, 2026FDA classification date |
| CRE Wireguided 6-8mm 240cmZ-2632-2026 · FDT | Boston Scientific Corporation | Recall | Jul 1, 2026FDA classification date |
| CRE Wireguided 8-10mm 240cmZ-2633-2026 · FDT | Boston Scientific Corporation | Recall | Jul 1, 2026FDA classification date |
| CRE Wireguided 10-12mm 240cmZ-2634-2026 · FDT | Boston Scientific Corporation | Recall | Jul 1, 2026FDA classification date |
| CRE Wireguided 12-15mm 240cmZ-2635-2026 · FDT | Boston Scientific Corporation | Recall | Jul 1, 2026FDA classification date |
| CRE Wireguided 15-18mm 240cmZ-2636-2026 · FDT | Boston Scientific Corporation | Recall | Jul 1, 2026FDA classification date |
| CRE Wireguided 18-20mm 240cmZ-2637-2026 · FDT | Boston Scientific Corporation | Recall | Jul 1, 2026FDA classification date |
| Intera Oncology INTERA 3000 Hepatic Artery Infusion Pump, AP-0300H, implantable drug delivery deviceZ-2580-2026 · LKK | Boston Scientific Corporation | Recall | Jun 25, 2026FDA classification date |
| RIVOS EUS Access Device (M00553900)K260428 · ODG | Boston Scientific Corporation | 510(k) | Jun 17, 2026FDA decision date |
| Boston Scientific CSK Electrodes: REF: CSK-TC10, CSK Electrode, STAINLESS STEEL, 10 cm x 28 ga (0.36 mm) REF: CSK-TC10-3M,CSK Electrode, STAINLES…Z-2402-2026 · GXI | Boston Scientific Neuromodulation Corporation | Recall | Jun 11, 2026FDA classification date |
| Boston Scientific TCN Electrodes: REF: TCN-5, TCN Electrode, NITINOL, 5 cm x 0.45 mm (0.0175 in); REF:TCN-10, TCN Electrode, NITINOL, 10 cm x 0.4…Z-2403-2026 · GXI | Boston Scientific Neuromodulation Corporation | Recall | Jun 11, 2026FDA classification date |
FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Keep this research moving.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.